This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Lin, M.-T. Articles by Kuo, M.-L. Search for Related Content PubMed PubMed Citation Articles by Lin, M.-T. Articles by Kuo, M.-L.

Cyr61 Induces Gastric Cancer Cell Motility/Invasion via Activation of the Integrin/Nuclear Factor-B/Cyclooxygenase-2 Signaling Pathway

Authors' Affiliations: Departments of ¹ Primary Care Medicine, ² Surgery, ³ Pediatrics, and ⁴ Pathology, National Taiwan University Hospital; ⁵ Laboratory of Molecular and Cellular Toxicology, Institute of Toxicology, College of Medicine; and ⁶ Angiogenesis Center, National Taiwan University, Taipei, Taiwan; and ⁷ Departments of Internal Medicine and Health, Executive Yuan, Tao-Yuan General Hospital, Taoyuan, Taiwan

Requests for reprints: Min-Liang Kuo, Laboratory of Molecular and Cellular Toxicology, Institute of Toxicology, College of Medicine, National Taiwan University, No. 1, Section 1, Jen-Ai Road, Taipei 100, Taiwan. Phone: 011-886-2-2312-3456-8607; Fax: 011-886-2-2341-0217; E-mail: toxkml{at}ha.mc.ntu.edu.tw.

Purpose: Cysteine-rich 61 (Cyr61/CCN1) is involved in many different types of tumor development and progression. Nonetheless, the role of Cyr61 in human gastric cancer has not yet been fully characterized.

Experimental design: We addressed the issue by immunohistochemical staining of 81 gastric adenocarcinoma specimens. Liposome-mediated transfection was used to introduce a Cyr61 expression vector into gastric cancer AGS cell lines. Transfectants were tested in invasion assay by a Boyden chamber. Furthermore, a cyclooxygenase-2 (COX-2) reporter assay and gel mobility shift assay were done to investigate the potential signal pathway of Cyr61.

Results: Patients with gastric adenocarcinoma whose tumor displayed high expression of Cyr61 correlated well with aggressive lymph node metastasis, more advanced tumor stage, histologic diffuse type, and early recurrence. Stable transfection of Cyr61 into the AGS cell line strongly enhanced its invasive activity. The overexpression of Cyr61 into AGS cells significantly increased the expression of COX-2 mRNA, protein, and enzymatic activity. Gel mobility shift assays further showed that the nuclear factor-B (NF-B) pathway was evidently activated in Cyr61-expressing AGS cells. Function-neutralizing antibody to vß3 but not vß5 effectively suppressed Cyr61-mediated NF-B activation, COX-2 gene expression, and cell invasiveness.

Conclusions: Cyr61 may contribute to the malignant progression of gastric cancer by promoting tumor cell motility/invasion through up-regulation of the functional COX-2 via an integrin vß3/NF-B-dependent pathway.

This article has been cited by other articles:

				M.-T. Lin, I-H. Kuo, C.-C. Chang, C.-Y. Chu, H.-Y. Chen, B.-R. Lin, M. Sureshbabu, H.-J. Shih, and M.-L. Kuo Involvement of Hypoxia-inducing Factor-1{alpha}-dependent Plasminogen Activator Inhibitor-1 Up-regulation in Cyr61/CCN1-induced Gastric Cancer Cell Invasion J. Biol. Chem., June 6, 2008; 283(23): 15807 - 15815. [Abstract] [Full Text] [PDF]

				M.-T. Lin, C.-C. Chang, B.-R. Lin, H.-Y. Yang, C.-Y. Chu, M.-H. Wu, and M.-L. Kuo Elevated Expression of Cyr61 Enhances Peritoneal Dissemination of Gastric Cancer Cells through Integrin {alpha}2beta1 J. Biol. Chem., November 23, 2007; 282(47): 34594 - 34604. [Abstract] [Full Text] [PDF]

				B.-R. Lin, C.-C. Chang, L.-R. Chen, M.-H. Wu, M.-Y. Wang, I-H. Kuo, C.-Y. Chu, K.-J. Chang, P.-H. Lee, W.-J. Chen, et al. Cysteine-Rich 61 (CCN1) Enhances Chemotactic Migration, Transendothelial Cell Migration, and Intravasation by Concomitantly Up-Regulating Chemokine Receptor 1 and 2 Mol. Cancer Res., November 1, 2007; 5(11): 1111 - 1123. [Abstract] [Full Text] [PDF]

				S. D. MacLaughlan, W. A. Palomino, B. Mo, T. D. Lewis, R. A. Lininger, and B. A. Lessey Endometrial Expression of Cyr61: A Marker of Estrogenic Activity in Normal and Abnormal Endometrium Obstet. Gynecol., July 1, 2007; 110(1): 146 - 154. [Abstract] [Full Text] [PDF]

				A. Leask and D. J. Abraham All in the CCN family: essential matricellular signaling modulators emerge from the bunker J. Cell Sci., December 1, 2006; 119(23): 4803 - 4810. [Abstract] [Full Text] [PDF]